A proposed class-action lawsuit accuses 11 hospitals, the American Society of Health-System Pharmacists and a matching service of attempting to suppress wages for pharmacy residents. 

Florida regulators have requested that pharmacy benefit managers turn over detailed prescription data, including patients' names, birthdates, medications, prescribing providers and dispensing pharmacies, Bloomberg reported Feb. 28. 

The FDA has announced new labeling changes for all testosterone products following a review of clinical trial data, including a TRAVERSE study and postmarket ambulatory blood pressure studies. 

Amid growing concerns over rising prescription drug prices, lawmakers are ramping up efforts to scrutinize pharmacy benefit managers, Fox affiliate WBFF reported Feb. 26. 

Pharmacy leaders across the country are implementing initiatives to improve efficiency, reduce costs and enhance patient care.  

A group of compounding pharmacies has filed a lawsuit against the FDA, challenging the agency's decision to remove semaglutide — which is used to treat Type 2 diabetes and obesity — from the drug shortage list. 

AstraZeneca's experimental breast cancer drug camizestrant, when combined with a cyclin-dependent kinase inhibitor, has shown significant improvement in delaying disease progression in patients with hormone receptor-positive, HER2-negative advanced breast cancer. 

Integrated Delivery Networks (IDNs) face growing pressure to ensure medication access for the 45 million Americans living in pharmacy deserts. Accelerating pharmacy closures, an aging population and staffing shortages present a crisis that demands an urgent response from health systems.

The FDA has eliminated a longstanding requirement that patients taking clozapine, an antipsychotic used for treatment-resistant schizophrenia, to submit blood test results before their prescriptions can be filled. 

On Feb. 24, Avita Health System opened a retail pharmacy in Crestline, Ohio, after the town's only pharmacy closed.